2011
DOI: 10.1016/j.jbiotec.2010.10.072
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic relationship between polyhydroxyalkanoic acid and rhamnolipid synthesis in Pseudomonas aeruginosa: Comparative 13C NMR analysis of the products in wild-type and mutants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
25
0
4

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(30 citation statements)
references
References 36 publications
1
25
0
4
Order By: Relevance
“…4), it is clear that S is regulating nutrient homeostasis during the PHB cycle. RpoS was shown previously to have a role in polyhydroxyalkanoate (PHA) biosynthesis in Pseudomonas oleovorans (16,50). However, in Pseudomonas putida, an rpoS mutation resulted in an increased PHA degradation rate (46), similar to what was observed in this study.…”
Section: Discussionsupporting
confidence: 86%
“…4), it is clear that S is regulating nutrient homeostasis during the PHB cycle. RpoS was shown previously to have a role in polyhydroxyalkanoate (PHA) biosynthesis in Pseudomonas oleovorans (16,50). However, in Pseudomonas putida, an rpoS mutation resulted in an increased PHA degradation rate (46), similar to what was observed in this study.…”
Section: Discussionsupporting
confidence: 86%
“…A clear example is the enhanced rhamnolipid production in polyhydroxyalkanoate (PHA)-deficient mutants of B. thailandensis (Funston et al 2017). Contrarily, PHA-deficient mutants of P. aeruginosa did not produce significantly higher rhamnolipid yields compared to wild type; however, rhamnolipid-deficient mutants produced significantly higher yields of PHA (Choi et al 2011). …”
Section: Discussionmentioning
confidence: 99%
“…Thus, in those pseudomonads which are able to accumulate PHA MCL and secrete RL, both biosynthesis pathways compete for the same precursors. This becomes obvious in mutants defective in RL synthesis, as they show elevated PHA MCL accumulation (300,301). Figure 21 illustrates the biosynthesis of mono-or dirhamnolipids from 3-hydroxyacyl-ACPs derived from de novo fatty acid synthesis.…”
Section: Rhamnolipid Biosynthesismentioning
confidence: 99%